Dr Jesse Levine Ritvo, MD | |
132 Main St, Montpelier, VT 05602-3226 | |
(802) 229-5115 | |
(802) 229-5013 |
Full Name | Dr Jesse Levine Ritvo |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 18 Years |
Location | 132 Main St, Montpelier, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558480707 | NPI | - | NPPES |
1017550 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 042-0011952 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Central Vermont Medical Center | Barre, VT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
Last month, the British Medical Journal reported a fall in the number of young women attending smear tests. Now, two senior doctors warn that a new policy not to screen women aged 20-24 may be a factor in falling coverage and could increase the risk of cancer developing in young women.
Researchers at Uppsala University and University Children's Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy.
› Verified 6 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
Last month, the British Medical Journal reported a fall in the number of young women attending smear tests. Now, two senior doctors warn that a new policy not to screen women aged 20-24 may be a factor in falling coverage and could increase the risk of cancer developing in young women.
Researchers at Uppsala University and University Children's Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy.
› Verified 6 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
Last month, the British Medical Journal reported a fall in the number of young women attending smear tests. Now, two senior doctors warn that a new policy not to screen women aged 20-24 may be a factor in falling coverage and could increase the risk of cancer developing in young women.
Researchers at Uppsala University and University Children's Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jesse Levine Ritvo, MD 132 Main St, Montpelier, VT 05602-3226 Ph: (802) 229-5115 | Dr Jesse Levine Ritvo, MD 132 Main St, Montpelier, VT 05602-3226 Ph: (802) 229-5115 |
News Archive
Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus.
As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new study results that demonstrate hospitals could realize substantial savings by substituting Flexi-Seal FMS for traditional fecal management methods.
Last month, the British Medical Journal reported a fall in the number of young women attending smear tests. Now, two senior doctors warn that a new policy not to screen women aged 20-24 may be a factor in falling coverage and could increase the risk of cancer developing in young women.
Researchers at Uppsala University and University Children's Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy.
› Verified 6 days ago
Margaret Ann Bolton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9 Heaton St, Montpelier, VT 05602 Phone: 802-229-0591 | |
Alan Leonard Zaur, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 162 Elm St, Suite 4, Montpelier, VT 05602 Phone: 802-229-2017 Fax: 802-223-0150 | |
Mr. Eliot Brandon Seigle, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 19 Court Street, Montpelier, VT 05601 Phone: 802-223-5561 Fax: 802-223-5463 | |
Dr. Jonathan L. Weker, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 State St, Suite 245, Montpelier, VT 05602 Phone: 802-223-2266 | |
Dr. Samuel Evenson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 350 Fisher Rd, Montpelier, VT 05633 Phone: 802-828-3300 Fax: 802-828-2749 | |
Dr. Harlow G Ballard Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 250 Main St, Suite 201, Montpelier, VT 05602 Phone: 802-223-2228 Fax: 802-778-0278 | |
Dr. James Scott Stone, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 73 Main St, Box 28, Room 18, Montpelier, VT 05602 Phone: 802-223-2633 Fax: 802-225-8971 |